Merck receives EU committee approval recommendation for bladder cancer drug combo

May 22, 2026 7:55 AM

Merck (NYSE: MRK) announced that the European Medicines Agency's Committee for Medicinal Products for Human Use adopted a positive opinion ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found